Home > News > Novel Gene Therapy Effectively Reduces Asthma Symptoms in Mice
October 31st, 2003
Novel Gene Therapy Effectively Reduces Asthma Symptoms in Mice
A novel nasal spray containing minuscule particles that deliver therapeutic protein-producing genes effectively reduces allergen-induced airway inflammation and hyper-reactivity, the hallmark symptoms of asthma. "By treating asthmatic mice with this gene therapy, we have allowed their lungs to produce the protein, interferon gamma, that is needed to reduce asthmatic symptoms," said Shyam S. Mohapatra, PhD, principal investigator. Mohapatra and his team selected chitosan nanoparticles as a delivery method for interferon gamma gene.
Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014
NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014
SentiMag® Now Available in Australia and New Zealand July 21st, 2014
More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014